Week 5 Flashcards
General somatic afferent fibers
Bring conscious/unconscious sensory memory from body wall and limbs
General visceral afferent fibers
Bring sensory information from visceral structures to CNS
General somatic efferent fibers
Innervation of voluntary skeletal muscles
General visceral efferent fibers
Innervation of cardiac muscles, smooth muscles, and glands
Dorsal root ganglions
Afferent nerve fibers
Dorsal horn
Entry of sensory information
Ventral horn
Location of motor neurons
Lateral Horn (Thoracolumbar)
T1-L2Location of preganglionic sympathetic neurons
Craniosacral preganglionic nerves
Parasympathetic originsBrainstem and S2-S4
Path of efferent sympathetic nerve transmission
Information from CNS –> Travel down to spinal cord –> Leave through lateral horn via ventral root –> Enter spinal nerve –> Enter sympathetic ganglion via white ramus –> Exit sympathetic ganglion via gray ramus –> Travel through spinal nerve to target
White ramus
Myelinated connection between spinal nerve and sympathetic ganglionOnly T1-L2
Gray ramus
Unmyelinated connection between sympathetic ganglion and spinal nerveAll levels
Path of efferent sympathetic nerve transmission (to cervical/lumbar area)
Information from CNS –> Travel down to spinal cord –> Leave through lateral horn via ventral root –> Enter spinal nerve –> Enter sympathetic ganglion via white ramus –> TRAVEL UP OR DOWN SYMPATHETIC CHAIN –> Synapse –> Exit sympathetic ganglion via gray ramus –> Travel through spinal nerve to target
Tyrosine –> Epinephrine synthesis pathway
Tyrosine –> DOPA –> Dopamine –> Norepinephrine –> Epinephrine
Neurotransmitter synthesis enzymes (Tyrosine –> Epi)
Tyrosine HydroxylaseDOPA decarboxylase D-beta-hydroxylasePNMT
Major mechanism for termination of NE action
Reuptake pumpUptake-1
Monoamine oxidase
Oxidizes NE to be degraded
Cocaine
Inhibits NE re-uptake into nerve terminalMore NE –> enhanced response
Imipramine
Tricyclic antidepressantInhibits NE reuptake
Tyramine
Indirectly acting sympathomimeticMimics NE activity by using NETaken up by uptake-1 pump –> oxidized by MAOIf MAO-inhibitor –> Not oxidized –> displaces NE from vesicles
Resperpine
Root of Rauwolfia serpentinaInhibits vesicular uptake of NE –> depletes vesicle so less NT when released
D-beta hydroxylase location
Within vesicle, released during exocytosis
Readily Reversible AChE inhibitor
Binds to active site but no covalent bond formation
Intermediate reversible AChE inhibitor
Covalent bond formation and then bond hydrolyzed - carbamates
Irreversible AChE inhibitor
Non hydrolysable covalent bondOrganophosphate
Regeneration
Proliferation of cells and tissue with host replacement tissueLiver regeneration after resection
Repair
Combination regeneration and deposition of collagen (scar formation)Dermal wound healing
Stimulatory control of cell proliferation and growth
Growth factors and cytokinesHormonesCell-cell interactionsCell matrix interaction
Inhibitory control of cell proliferation and growth
Contact inhibitionGrowth factors
Stages of liver regeneration
Priming: IL-6 produced by Kuppfer cells make hepatocytes competent to respond to growth factorsGrowth factors: HGF, TGF-a act on primed hepatocytesHepatocytes move from G0 to G1 phase of cell cycle
Kuppfer cells
Resident liver macrophages
Oval cells
Hepatic ductal cells which accumulate during toxin exposureReplace parenchymal cells and restore function
Primary union of skin incision
Clean injurySpace clots –> neutrophil infiltrate –> epithelial cell migration/proliferation –> Macrophage –> Granulation tissue forms –> Collagen begins to bridge wound ~1 week
Angiogenesis
Blood vessel formationNotch signaling pathway
Secondary union of skin
Larger wound, more inflammation, more granulation tissue fills defect, longer healing timeWound contraction reduces size
Labile cells
Continuously dividingEpidermis, bone marrow, GI mucosa
Stable/Quiescent cells
Potential to divideHepatocytes, renal tubular epithelium, endothelium, connective tissue, smooth muscle
Permanent cells
Unable to divideNeurons, cardiac myocytes, skeletal muscle
Determinants of quality of healing
Regenerative capacity, stromal injury, contamination, proliferative activity of connective tissue
Excessive repair
Hypertrophic scarsKeloids
Characteristics of benign neoplasms
Pushing, smooth borderHistology looks like normal tissueDo no metastasize
Malignant neoplasms
Hard tumorInfiltrating, invasive locallyLack of differentiation: anaplasiaMay extend into adjacent tissue or invade nerve sheaths (perineural invasion) and blood vessels (vascular invasion)
Invasion of matrix across basement membrane
Tumor cells lose cohesion –> secrete proteolytic enzymes –> Attach to extracellular matrix via receptors for laminin/fibronectin –> locomote through matrix
Alpha-1 receptor activation effects
Vasoconstriction
Alpha-2 receptor activation effect
Inhibition of transmitter release (NE and ACh)
Beta-1 receptor activation effects
Increased cardiac rate (SA node) and force (and output)
Beta-2 receptor activation effects
Bronchodilation, vasodilation Only Epinephrine
Beta-1 agonist activity
Increased cardiac output, HR
Beta-1 antagonist activity
Prevent increase in cardiac output
Beta-2 agonist activity
Dilate airways, decrease resistance
Beta-2 antagonist activity
Constrict airways, increase resistance
Alpha-1 agonist activity
Constrict blood vessels, increase BP
Alpha-1 antagonist activity
Dilate vessels, decrease BP
Pheochromocytoma
Tumor of adrenal gland, releases Epi and NEIncrease BP, HRHeadache, sweating, hypertensive crisis
Route 1 for sympathetic transmission
Preganglionic axon enters sympathetic chain (white ramus) –> synapse –> exit via gray ramus –> postganglionic axon to target
Route 2 for sympathetic transmission
Preganglionic axon enters sympathetic chain (white ramus) –> Travel up/down sympathetic chain –> synapse –> postganglionic axon to target
Route 3 for sympathetic transmission (thoracic)
Preganglionic axon enters sympathetic chain (white ramus) –> synapse –> Travel to heart via splanchnic nerve
Route 4 for sympathetic transmission (Abdominal)
Preganglionic axon enters sympathetic chain (white ramus) –> Splanchnic nerve to target organ –> synapse and postganglionic innervation
Parasympathetic preganglionic synapse location
Intramural ganglia on wall of visceral structure
Vagus nerve
Parasympathetic nerve which branches off to target organsInnervates GI tract up to splenic flexure
Pelvic splanchnic nerves
Sacral portion of parasympathetic divisionPelvic viscera, GI tract distal to splenic flexure
Heart muscle sympathetic vs parasympathetic
S: Increase rate/forceP: Decrease rate
Bladder urethra sympathetic vs parasympathetic
S: Detrusor relaxation, constriction of sphincterP: Detrusor constriction, relaxation of sphincter
Lungs sympathetic vs parasympathetic
S: BronchodilationP: Bronchoconstriction
GI organs sympathetic vs parasympathetic
S: Decreased peristalsis/secretionP: Increased peristalsis/secretion
Eye sympathetic vs parasympathetic
S: DilationP: Constriction
Glands sympathetic vs parasympathetic
S: Less secretionP: Increased secretion
Phenylephrine
Alpha adrenergic agonist
Epinephrine
Alpha and Beta adrenergic agonist
Scopolamine
Muscarinic receptor antagonist
Pupil innervation
Cholinergic and AdrenergicACh = parasympathetic = constriction = miosis Circular muscle contractionNE = sympathetic = dilation Radial muscle contraction
Ciliary muscle innervation
M: ContractionBeta2: RelaxationPrimarily Parasympathetic innervation
Vascular smooth muscle innervation
Single innervation: SympatheticAlpha1: ContractionBeta2: RelaxationNO CHOLINERGIC
Muscarinic receptors on endothelium
Can release NO which relaxes VSM
Sinoatrial node innervation
Dual innervation: Primarily parasympatheticACh & NEBeta1: Increase HR, contractilityBeta2: Only EpiM: Decrease HR
Atropine
Muscarinic receptor antagonist
GI innervation
Dual innervation: primarily sympatheticM: Contract, peristalsisBeta2: Relax, no peristalsis
Sphincter muscle innervation
Dual innervation: primarily sympatheticMuscarinic receptor mediated relaxation (via NO)Alpha1: Contraction, retention
Isoproterenol and VSM
Activates B2 –> relaxation
Sarin gas
AChE inhibitorIrreversible
Wound contraction
Reduction of size of defectMyofibroblasts3-5 days after injury
Wound strength
Early (week 1)- 5-10% original strength- Fibrin, re-epithelializationFirst month- Collagen content- 15%Month-years- Collagen linking/remodeling- Max 60% original strength
Phases of wound strength
LagRapid increase Slow increasePlateau
Keloids vs hypertrophic scars: Similarities
Excessive granulation tissueExcessive collagenInitial morphological similarity
Keloids vs Hypertrophic scarsL Differences
Keloids do not regress, recur, extend beyond injury site
Biological aging of cells: Increase and decrease
Increase: Organelle damageDecrease: Oxidative phosphorylation, protein synthesis, nutrient uptake, DNA repair
Cardiovascular aging
Intimal thickeningVascular stiffnessHypertension, atherosclerosis
Urinary aging
Bladder elasticity declines, glomerulosclerosisBladder control problems decline in kidney function
Respiratory aging
Loss of elasticity, immunityInfection, reduced exercise tolerance
Endocrine system
Hormone levels changeAge associated disease, diabetes, hypotension
Liver aging
Decreased blood flow, loss of hepatocytesDrug metabolism declines, Adverse drug reactions
GI aging
Gi hormone decrease, smooth muscle atrophyConstipation, Reflux, nutritional defecits
Trauma and aging
Inflammation and re-epithelialization is delayed
Cumulative damage and aging - Accumulation
Waste product accumulation: LipofuscinAdvanced glycation end products- non enzymatic addition of sugars to proteins- Affect multiple tissues-Skin collagen and lens
Hutchinson Gilford Progeria syndrome
Hydrocephalic appearancePremature aging lookAge associated pathology - osteoporosis, insulin resistance, CVDLamin A gene-Splice disorder –> Deletes 50 amino acidsNew protein is progerinDisrupts nuclear envelope
Werner’s Syndrome
Autosomal recessivePremature wrinkling and graying, age related pathologyCancerMutant gene: WRN-1 (helicase)
Telomeres
Added by telomeraseLength shortens after division –> trigger p53
Resveratrol
Extends lifespan in lower organisms
Rapamycin
Increases lifespanEnhances progerin clearanceImmunosuppressive
HPV protein E6
Mimics MDM2Ubiquination and degradation of p53 protein–> loss of tumor suppressor
HPV protein E7
Eradicates function of RBRemove brake against proliferation
EBV in immune suppressed patients
Activates BCL2Prevents apoptosis
Chronic inflammation and cancer promotion
Release factors for cell proliferation by leukocytes or by protease digestion of ECM
HER2/neu
Amplification in breast cancer
N-myc
Amplification in neuroblastoma
Acute leukemias defect
Translocation
ZAP-70
Chronic lymphocytic leukemia
Chronic phase CML
Elevated WBC, eosiniphilia and basophilia
Accelerated phase CML
20% blasts
Imatinib (Gleevec)
Inhibits bcr-abl tyrosine kinaseStops leukemia
Familial breast cancer cause
BRCA-1, BRCA-2
Familial polyposis cause
APC tumor supressor
Hereditary nonpolyposis colon cancer cause
Double stranded DNA repair genes
Xeroderma pigmentosum cause
Nucleotide excision repair genesUV light exposure –> Pyrimidine-pyrimidine dimers
Order for cancerInitiator/promotor
Initiator first then promotor
HTLV I
T-cell leukemia/lymphomaCommon in Japan and Caribbean
SA node resting tone and effect of ganglionic blocker
ParasympatheticGanglionic blocker = tachycardia
Myocardium ventricle resting tone and effect of ganglionic blocker
SympatheticGanglionic blocker = Reduced contractility
Basic steps of wound healing
InflammationGranulation tissue formationRe-epithelizalizationWound contraction and ECM deposition
Stimuli for GVA (pain)
pH (ischemia/hypoxia)distention (stretch)Spasms of strong activationChemical irritantsLowering of membrane potential for stimulation
Granulation cell
ECMInflammatory cellsFibroblastsBlood vessels
Wound healing cells
MyofibroblastsSmooth muscleParenchymalLeukocytesEndothelialFibroblasts
Cytokines for wound healing
Platelet derived GFTGF betaBasic Fibrobalst GFEpidermal GFVascular endothelial GFIL-1,8
Growth factor functions
ProliferationLocomotionDifferentiationAngiogenesisSurvival
miRNA tumor suppressor
145Breast, colon
Her2/neu treatment
Monoclonal antibody
Perineoplastic syndrome
CushingsHypercalcemiaSIA-Dehydrogenase
Rituximab
Drug that acts on CD20 of B cells